Biopharm Company Located to Innovation Campus

A biopharmaceutical company that designs components that help vaccines boost immunity will move into the Biotech Connector at Nebraska Innovation Campus, the research park announced.

Adjuvance, started by Hebron native Dr. Tyler Martin, will use a $1.5 million grant from the National Institutes of Health to conduct further research on the vaccine boosters in labs available at Innovation Campus.

“Our company started at Memorial Sloan Kettering Cancer Center and we are pleased to open new lab space at NIC to advance our projects in a cost-effective manner,” Martin said in a news release.

The Biotech Connector, which will provide wet lab space for Adjuvance, is the result of a partnership between the research park, the University of Nebraska-Lincoln, Invest Nebraska, the Department of Economic Development and Bio Nebraska.

It allows for innovators and entrepreneurs to access physical resources as well as other skills training to promote biotechnology companies in Nebraska.

“Today’s announcement is significant and a wonderful example of a Nebraskan returning home to positively impact our state and industry,” said Phil Kozera, executive director of the Bio Nebraska Life Sciences Association.

“These types of collaborations are critical to growing Nebraska’s biotech community and are a result of shared resources and vision for what’s possible for the state’s 21st century economy,” he added.